已收盘 08-16 16:00:00 美东时间
0.000
0.00%
Dosed first patient in Phase 2b RewinD-LB study evaluating neflamapimod in patients with dementia with Lewy bodies (DLB) Multiple peer-reviewed journal publications and a conference presenta...
2023-11-13 20:00
BOSTON, Sept. 5, 2023 /PRNewswire/ -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced that the...
2023-09-05 19:00
Approximately 71% of Stockholders Voted in Favor of the TransactionDiffusion An...
2023-08-16 04:01
BOSTON, Aug. 14, 2023 /PRNewswire/ -- EIP Pharma Inc. ("EIP Pharma" or the "Company"), a privately held clinical-stage company focused on developing treatments for neurodegenerative diseases...
2023-08-14 19:00
On Thursday, 109 companies set new 52-week lows.
2023-07-07 00:58
NEW YORK, May 22, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
2023-05-23 10:14
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) saw a significant gro...
2023-03-11 23:33
Stock analysts at StockNews.com initiated coverage on shares of Diffusion Pharm...
2023-02-22 16:23
Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) and Forte Biosciences (NAS...
2023-02-21 14:22
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a s...
2023-02-12 09:41